Brent Warner
No más puestos en curso
Fortuna: 1 M $ al 31/05/2024
Perfil
Brent Warner served as Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
He then became President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024.
Mr. Warner obtained an undergraduate degree and an MBA from Northwood University (Michigan).
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
01/03/2024 | 419 040 ( 0.43% ) | 1 M $ | 31/05/2024 |
Antiguos cargos conocidos de Brent Warner.
Empresas | Cargo | Fin |
---|---|---|
POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2024 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | 01/02/2022 |
Formación de Brent Warner.
Northwood University (Michigan) | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
POSEIDA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Brent Warner